Among all GTF3 members, GTF3A was particularly highly expressed in CRC compared to normal tissues, whereas GTF3B, GTF3C1, and GTF3C2 had low expression levels in other types of cancers such as brain and central nervous system cancers, esophageal cancer, and leukemia (Figure 1). This evidence concerns the gene GTF2IRD1 and esophageal cancer.